Successful treatment of a patient with symptomatic long QT syndrome type 3 using ranolazine combined with a beta-blocker

Int J Cardiol. 2014 Jan 15;171(1):90-2. doi: 10.1016/j.ijcard.2013.11.066. Epub 2013 Dec 4.
No abstract available

Keywords: Beta-blocker; Late inward sodium current; Long QT syndrome type 3; N1325S; Ranolazine; SCN5a.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acetanilides / administration & dosage*
  • Adrenergic beta-Antagonists / administration & dosage*
  • Adult
  • Cardiac Conduction System Disease
  • Drug Therapy, Combination
  • Electrocardiography, Ambulatory / methods
  • Female
  • Humans
  • Long QT Syndrome / diagnosis*
  • Long QT Syndrome / drug therapy*
  • Long QT Syndrome / physiopathology
  • Piperazines / administration & dosage*
  • Ranolazine
  • Sodium Channel Blockers / administration & dosage
  • Treatment Outcome

Substances

  • Acetanilides
  • Adrenergic beta-Antagonists
  • Piperazines
  • Sodium Channel Blockers
  • Ranolazine

Supplementary concepts

  • Long QT syndrome type 3